BeStock  

Teleflex TFX

US equityMarket cap rank #1798Medical Instruments & Supplies
$161.58 −$1.82 (-1.11%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $161.58 0.00%
Open$164.07
Prev close$163.40
Day range$161.35 – $166.52
Volume655.0K
Market cap$6.41B
P/E (TTM)21.3
Dividend yield0.84%

Earnings

Average move on report day±7.7%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+11.6%
Worst reaction-21.7%

Stock move on the day after each report

-5.3%2023/Q4-6.1%2024/Q1+6.8%2024/Q2-14.5%2024/Q3-21.7%2024/Q4-8.2%2025/Q1+4.9%2025/Q2-13.0%2025/Q3+6.4%2025/Q4+6.9%2026/Q1+1.5%2026/Q2+1.5%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026Pre Market±9.5%+1.52%Within range
2026/Q26 Aug 2026Pre Market±9.1%+1.54%Within range
2026/Q17 May 2026Pre Market±7.0%+6.86%Within range
2025/Q426 Feb 2026Pre Market±7.8%+6.37%Within range
2025/Q36 Nov 2025Pre Market±11.0%-13.02%Bigger than priced
2025/Q231 Jul 2025Pre Market±8.3%+4.91%Within range
2025/Q11 May 2025Pre Market±9.8%-8.16%Within range
2024/Q427 Feb 2025Pre Market±8.5%-21.69%Bigger than priced
2024/Q331 Oct 2024Pre Market–-14.52%–
2024/Q21 Aug 2024Pre Market±8.2%+6.80%Within range
2024/Q12 May 2024Pre Market–-6.06%–
2023/Q422 Feb 2024Pre Market±9.0%-5.28%Within range
2023/Q32 Nov 2023Pre Market–+11.56%–
2023/Q23 Aug 2023None±7.0%-3.68%Within range
2023/Q14 May 2023Pre Market±7.1%-8.53%Bigger than priced
2022/Q423 Feb 2023None±14.3%-2.07%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Vascular$243.45M 42.9%
  • Interventional$210.30M 37.0%
  • Surgical$114.03M 20.1%

Latest reported quarter: Q3, ended Sep 2026

Revenue$567.78M+0.1% YoY
Operating profit$105.08M+160.1% YoY
Net profit$927.43M+326.8% YoY
Diluted EPS$22.28+341.1% YoY
Free cash flow$126.15M+43.1% YoY
Operating cash flow$147.76M

Revenue, last 8 quarters

$-552.4MDec '24$414.3MMar '25$442.5MJun '25$566.9MSep '25$569.0MDec '25$548.3MMar '26$570.3MJun '26$567.8MSep '26

Net profit, last 8 quarters

$-136.7MDec '24$95.0MMar '25$122.6MJun '25$-408.9MSep '25$-714.3MDec '25$-8.2MMar '26$99.7MJun '26$927.4MSep '26

Profitability & balance sheet

Gross margin58.3%
Operating margin11.2%
Net margin13.5%
Return on equity8.3%
Return on assets4.3%
Return on invested capital6.5%
Current ratio2.01
Liabilities / assets45.0%
Cash & investments$430.47M
Total debt$1.68B
Net cash (debt)-$1.25B
Free cash flow / sales16.2%

Discussion

No comments yet — be the first to weigh in on TFX.

Sign in to join the discussion.

Scroll to Top